/ Print /

Pharmacy

Three Pricing Models That Address the High-Cost Gene, Cell Therapies
Three Pricing Models That Address the High-Cost Gene, Cell TherapiesHere are three innovative structures in pricing models to address the high-cost of curative therapies.
How to Treat Substance Abuse with a Model of Ongoing Care
How to Treat Substance Abuse with a Model of Ongoing CareHere's how one federally qualified health center in southcentral Pennsylvania is tackling the opioid crisis in its community.
The Blood Pressure Drugs that are Linked to Lower Mortality
The Blood Pressure Drugs that are Linked to Lower MortalityA study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
Payers Seize Opportunities to Control Diabetes Drug Costs
Payers Seize Opportunities to Control Diabetes Drug CostsDiabetes drug spending is on the rise, but there are ways to control it.
Do Preferred Pharmacy Networks Save Money for Part D Beneficiaries?
Do Preferred Pharmacy Networks Save Money for Part D Beneficiaries?A new Oliver Wyman reveals costly findings about Part D beneficiaries enrolled in plans without preferred pharmacy networks.
Opinion: Time to Manage ‘Clinically Superfluous’ Drug Products to Control CostsPBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.
Why Efforts to Curb Opioid Use Haven’t Translated to the Pediatric PopulationA new study shows efforts to reduce prescription opioid use in adults has not curtailed the incidence of pediatric opioid ingestions. Find out why.
Readmission Cost Savings are a Reality with Enhanced Patient EngagementReduce readmissions by focusing on better engagement with patients and improving coordination from inpatient to outpatient settings.
Will UnitedHealthcare’s Direct-to-Consumer Pharma Rebates Curb Rising Costs?UnitedHealthcare will pass on pharmacy discounts directly to some consumers, signaling the next wave of disruption in healthcare, say industry watchers.
Migraine Pipeline and Impact Updates: What Health Execs Should Know
Migraine Pipeline and Impact Updates: What Health Execs Should KnowA new report highlights physical, social, and economic challenges of migraine.